BoneKEy reportsPub Date : 2015-04-15eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.32
Nikola Baschuk, Jay Rautela, Belinda S Parker
{"title":"Bone specific immunity and its impact on metastasis.","authors":"Nikola Baschuk, Jay Rautela, Belinda S Parker","doi":"10.1038/bonekey.2015.32","DOIUrl":"https://doi.org/10.1038/bonekey.2015.32","url":null,"abstract":"<p><p>Bone is one of the most common sites of metastasis in solid malignancy. Contributing to this osteotropism are the dynamic interactions between tumor cells and the numerous cell types resident in the normal bone, particularly osteoclasts and osteoblasts, which create a tumor supporting microenvironment. However, disseminated cells are detected in the bone marrow long before evidence of metastatic outgrowth, and it is likely that prolonged survival is also reliant on immunoescape. Compared with other peripheral organs such as the lung and spleen, the bone marrow constitutes a unique immune cell compartment that likely provides an immune privileged niche for disseminated tumor cells. This includes the large proportions of immunosuppressive cells, including myeloid derived suppressor cells and regulatory T cells, that blunt the activity of cytotoxic lymphocytes involved in tumor immunosurveillance. This review highlights key aspects of the osteoimmune landscape and emerging mechanisms by which tumor cells create or co-opt an immunosuppressed niche to support their outgrowth in bone. Future studies in this field are likely to shed light on the differences in immunoregulation between the bone and other sites including the primary tumor, and the potential for immunotherapeutics in treating disseminated disease in the bone. However, more immunocompetent models, that recapitulate tumor heterogeneity and bone metastasis need to be developed to accelerate this field. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"665"},"PeriodicalIF":0.0,"publicationDate":"2015-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.32","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33247659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-04-08eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.29
Marie-Hélène Lafage-Proust, Bernard Roche, Max Langer, Damien Cleret, Arnaud Vanden Bossche, Thomas Olivier, Laurence Vico
{"title":"Assessment of bone vascularization and its role in bone remodeling.","authors":"Marie-Hélène Lafage-Proust, Bernard Roche, Max Langer, Damien Cleret, Arnaud Vanden Bossche, Thomas Olivier, Laurence Vico","doi":"10.1038/bonekey.2015.29","DOIUrl":"https://doi.org/10.1038/bonekey.2015.29","url":null,"abstract":"<p><p>Bone is a composite organ that fulfils several interconnected functions, which may conflict with each other in pathological conditions. Bone vascularization is at the interface between these functions. The roles of bone vascularization are better documented in bone development, growth and modeling than in bone remodeling. However, every bone remodeling unit is associated with a capillary in both cortical and trabecular envelopes. Here we summarize the most recent data on vessel involvement in bone remodeling, and we present the characteristics of bone vascularization. Finally, we describe the various techniques used for bone vessel imaging and quantitative assessment, including histology, immunohistochemistry, microtomography and intravital microscopy. Studying the role of vascularization in adult bone should provide benefits for the understanding and treatment of metabolic bone diseases. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"662"},"PeriodicalIF":0.0,"publicationDate":"2015-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.29","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33086853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-04-01eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.33
Rafik Mansouri, Eric Haÿ, Pierre J Marie, Dominique Modrowski
{"title":"Role of syndecan-2 in osteoblast biology and pathology.","authors":"Rafik Mansouri, Eric Haÿ, Pierre J Marie, Dominique Modrowski","doi":"10.1038/bonekey.2015.33","DOIUrl":"https://doi.org/10.1038/bonekey.2015.33","url":null,"abstract":"<p><p>Syndecans 1-4 are a family of transmembrane proteins composed of a core protein and glycosaminoglycan chains. Although the four syndecans have common functions, they appear to be connected to different signaling pathways, and their expression occurs in a cell- and development-specific pattern. In contrast to other syndecans, syndecan-2 expression increases during osteoblast differentiation. Mechanistically, syndecan-2 exerts multiple functions in cells of the osteoblast lineage as it serves as a co-receptor for fibroblast growth factors and Wnt proteins and controls cell adhesion, proliferation, differentiation and apoptosis. Recent studies indicate that syndecan-2 also contributes to osteosarcoma cell response to cytotoxic agents through interactions with Wnt/β-catenin signaling. Here we summarize our current understanding of the role of syndecan-2 in the control of osteoblast biology and pathology and discuss how syndecan-2 acts as a modulator of the bone cell microenvironment. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"666"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33194630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-03-18eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.10
Penelope D Ottewell, Liam O'Donnell, Ingunn Holen
{"title":"Molecular alterations that drive breast cancer metastasis to bone.","authors":"Penelope D Ottewell, Liam O'Donnell, Ingunn Holen","doi":"10.1038/bonekey.2015.10","DOIUrl":"https://doi.org/10.1038/bonekey.2015.10","url":null,"abstract":"<p><p>Epithelial cancers including breast and prostate commonly progress to form incurable bone metastases. For this to occur, cancer cells must adapt their phenotype and behaviour to enable detachment from the primary tumour, invasion into the vasculature, and homing to and subsequent colonisation of bone. It is widely accepted that the metastatic process is driven by the transformation of cancer cells from a sessile epithelial to a motile mesenchymal phenotype through epithelial-mesenchymal transition (EMT). Dissemination of these motile cells into the circulation provides the conduit for cells to metastasise to distant organs. However, accumulating evidence suggests that EMT is not sufficient for metastasis to occur and that specific tissue-homing factors are required for tumour cells to lodge and grow in bone. Once tumour cells are disseminated in the bone environment, they can revert into an epithelial phenotype through the reverse process of mesenchymal-epithelial transition (MET) and form secondary tumours. In this review, we describe the molecular alterations undertaken by breast cancer cells at each stage of the metastatic cascade and discuss how these changes facilitate bone metastasis. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"643"},"PeriodicalIF":0.0,"publicationDate":"2015-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33194628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-03-18eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.11
Zeynep Seref-Ferlengez, Oran D Kennedy, Mitchell B Schaffler
{"title":"Bone microdamage, remodeling and bone fragility: how much damage is too much damage?","authors":"Zeynep Seref-Ferlengez, Oran D Kennedy, Mitchell B Schaffler","doi":"10.1038/bonekey.2015.11","DOIUrl":"https://doi.org/10.1038/bonekey.2015.11","url":null,"abstract":"<p><p>Microdamage resulting from fatigue or 'wear and tear' loading contributes to bone fragility; however, the full extent of its influence is not completely understood. Linear microcracks (∼50-100 μm) and diffuse damage (clusters of sublamellar-sized cracks) are the two major bone microdamage types, each with different mechanical and biological consequences. Healthy bone, due to its numerous microstructural interfaces and its ability to affect matrix level repair, deals effectively with microdamage. From a material standpoint, healthy bone behaves much like engineering composites like carbon-fiber reinforced plastics. Both materials allow matrix damage to form during fatigue loading and use microstructural interfaces to dissipate energy and limit microcrack propagation to slow fracture. The terms fracture toughness and 'toughening mechanism', respectively, describe mechanical behavior and microstructural features that prevent crack growth and make it harder to fracture a material. Critically, toughness is independent of strength. In bone, primary toughening features include mineral and collagen interfaces, lamellae and tissue heterogeneity among osteons. The damage tolerance of bone and other composites can be overcome with sustained loading and/or matrix changes such that the microstructure no longer limits microcrack propagation. With reduced remodeling due to aging, disease or remodeling suppression, microdamage accumulation can occur along with loss of tissue heterogeneity. Both contribute additively to reduced fracture toughness. Thus, the answer to the key question for bone fragility of how much microdamage is too much is extremely complex. It ultimately depends on the interplay between matrix damage content, internal repair and effectiveness of matrix-toughening mechanisms. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"644"},"PeriodicalIF":0.0,"publicationDate":"2015-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.11","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33194629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-03-11eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.12
Max A Hammond, Joseph M Wallace
{"title":"Exercise prevents β-aminopropionitrile-induced morphological changes to type I collagen in murine bone.","authors":"Max A Hammond, Joseph M Wallace","doi":"10.1038/bonekey.2015.12","DOIUrl":"https://doi.org/10.1038/bonekey.2015.12","url":null,"abstract":"<p><p>This study evaluated the effects of reduced enzymatic crosslinking, exercise and the ability of exercise to prevent the deleterious impact of reduced crosslinking on collagen D-spacing. Eight-week-old female mice were divided into four weight-matched groups receiving daily injections of either phosphate-buffered saline (PBS) or 300 mg kg(-1) β-aminopropionitrile (BAPN) while undergoing normal cage activity (Sed) or 30 min per day of treadmill exercise (Ex) for 21 consecutive days. BAPN caused a downward shift in the D-spacing distribution in Sed BAPN compared with Sed PBS (P<0.001) but not in Ex BAPN (P=0.429), indicating that exercise can prevent changes in collagen morphology caused by BAPN. Exercise had no effect on D-spacing in PBS control mice (P=0.726), which suggests that exercise-induced increases in lysyl oxidase may be a possible mechanism for preventing BAPN-induced changes in D-spacing. The D-spacing changes were accompanied by an increase in mineral crystallinity/maturity due to the main effect of BAPN (P=0.016). However, no changes in nanoindentation, reference point indentation or other Raman spectroscopy parameters were observed. The ability of exercise to rescue BAPN-driven changes in collagen morphology necessitates further research into the use of mechanical stimulation as a preventative therapy for collagen-based diseases. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"645"},"PeriodicalIF":0.0,"publicationDate":"2015-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.12","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33152067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-03-11eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.9
Carine Le Goff, Valerie Cormier-Daire
{"title":"Chondrodysplasias and TGFβ signaling.","authors":"Carine Le Goff, Valerie Cormier-Daire","doi":"10.1038/bonekey.2015.9","DOIUrl":"https://doi.org/10.1038/bonekey.2015.9","url":null,"abstract":"<p><p>Human chondrodysplasias are a group of conditions that affect the cartilage. This review is focused on the involvement of transforming growth factor-β signaling in a group of chondrodysplasias, entitled acromelic dysplasia, characterized by short stature, short hands and restricted joint mobility. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"642"},"PeriodicalIF":0.0,"publicationDate":"2015-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33152066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-02-11eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.3
Juliet Compston
{"title":"HIV infection and osteoporosis.","authors":"Juliet Compston","doi":"10.1038/bonekey.2015.3","DOIUrl":"10.1038/bonekey.2015.3","url":null,"abstract":"<p><p>In the past two decades, the life expectancy of people living with HIV infection has increased significantly, and osteoporosis has emerged as a significant comorbidity. In addition to traditional risk factors for fracture, specific factors related to HIV infection are also likely to contribute, including antiretroviral therapy. The heterogeneity of the HIV-infected population in terms of age and ethnicity presents many challenges to the prevention and management of bone disease, and further studies are required to establish optimal approaches to risk assessment and treatment. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"636"},"PeriodicalIF":0.0,"publicationDate":"2015-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325555/pdf/bonekey20153.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33078208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-02-11eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.1
Barbara M Misof, Nadja Fratzl-Zelman, Eleftherios P Paschalis, Paul Roschger, Klaus Klaushofer
{"title":"Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects.","authors":"Barbara M Misof, Nadja Fratzl-Zelman, Eleftherios P Paschalis, Paul Roschger, Klaus Klaushofer","doi":"10.1038/bonekey.2015.1","DOIUrl":"https://doi.org/10.1038/bonekey.2015.1","url":null,"abstract":"<p><p>It is well established that long-term antiresorptive use is effective in the reduction of fracture risk in high bone turnover osteoporosis. Nevertheless, during recent years, concerns emerged that longer bone turnover reduction might favor the occurrence of fatigue fractures. However, the underlying mechanisms for both beneficial and suspected adverse effects are not fully understood yet. There is some evidence that their effects on the bone material characteristics have an important role. In principle, the composition and nanostructure of bone material, for example, collagen cross-links and mineral content and crystallinity, is highly dependent on tissue age. Bone turnover determines the age distribution of the bone structural units (BSUs) present in bone, which in turn is decisive for its intrinsic material properties. It is noteworthy that the effects of bone turnover reduction on bone material were observed to be dependent on the duration of the antiresorptive therapy. During the first 2-3 years, significant decreases in the heterogeneity of material properties such as mineralization of the BSUs have been observed. In the long term (5-10 years), the mineralization pattern reverts towards normal heterogeneity and degree of mineralization, with no signs of hypermineralization in the bone matrix. Nevertheless, it has been hypothesized that the occurrence of fatigue fractures (such as atypical femoral fractures) might be linked to a reduced ability of microdamage repair under antiresorptive therapy. The present article examines results from clinical studies after antiresorptive, in particular long-term, therapy with the aforementioned potentially positive or negative effects on bone material. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"634"},"PeriodicalIF":0.0,"publicationDate":"2015-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33077771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BoneKEy reportsPub Date : 2015-02-11eCollection Date: 2015-01-01DOI: 10.1038/bonekey.2015.2
Nerea Alonso, Gavin Lucas, Pirro Hysi
{"title":"Big data challenges in bone research: genome-wide association studies and next-generation sequencing.","authors":"Nerea Alonso, Gavin Lucas, Pirro Hysi","doi":"10.1038/bonekey.2015.2","DOIUrl":"https://doi.org/10.1038/bonekey.2015.2","url":null,"abstract":"<p><p>Genome-wide association studies (GWAS) have been developed as a practical method to identify genetic loci associated with disease by scanning multiple markers across the genome. Significant advances in the genetics of complex diseases have been made owing to advances in genotyping technologies, the progress of projects such as HapMap and 1000G and the emergence of genetics as a collaborative discipline. Because of its great potential to be used in parallel by multiple collaborators, it is important to adhere to strict protocols assuring data quality and analyses. Quality control analyses must be applied to each sample and each single-nucleotide polymorphism (SNP). The software package PLINK is capable of performing the whole range of necessary quality control tests. Genotype imputation has also been developed to substantially increase the power of GWAS methodology. Imputation permits the investigation of associations at genetic markers that are not directly genotyped. Results of individual GWAS reports can be combined through meta-analysis. Finally, next-generation sequencing (NGS) has gained popularity in recent years through its capacity to analyse a much greater number of markers across the genome. Although NGS platforms are capable of examining a higher number of SNPs compared with GWA studies, the results obtained by NGS require careful interpretation, as their biological correlation is incompletely understood. In this article, we will discuss the basic features of such protocols. </p>","PeriodicalId":72441,"journal":{"name":"BoneKEy reports","volume":" ","pages":"635"},"PeriodicalIF":0.0,"publicationDate":"2015-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/bonekey.2015.2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33078207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}